Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Norvasc
Generic name / active ingredient
amlodipine
Dosage-form class
Oral tablets: 2.5 mg, 5 mg and 10 mg (as listed in DailyMed NORVASC SPL v29; this dossier separately displays three 90-tablet bottle panels)
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • “2.5, 5 and 10 mg” distinguish tablet strengths in this U.S. label; they are not permission to add, halve or convert tablets freely. When strengths differ, first check the prescription label, target market and complete medicine name.
  • The label describes tablet shapes and debossing for different strengths. These are checking clues, not a way to authenticate a product, and do not establish that another market, version or maker has the same appearance.
  • If several blood-pressure, heart, pain, cold or supplement products are being used, bring each product's full name, strength, actual timing and symptom record to a pharmacist or clinician. Do not self-combine or replace products merely because packages mention blood pressure or the heart.
  • This U.S. public label does not replace the current label in the target market. Particularly with older age, multiple conditions or multiple medicines, confirm before starting, stopping, changing, splitting or changing strength.

Reviewed presentation examples — compare every field

  • 2.5 mg per tablet; 90-tablet bottleNDC 0069-1520-68
  • 5 mg per tablet; 90-tablet bottleNDC 0069-1530-68
  • 10 mg per tablet; 90-tablet bottleNDC 0069-1540-68

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image